![Paul Brennan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Brennan
Corporate Officer/Principal chez
EUPRAXIA PHARMACEUTICALS INC.
Fortune : 343 865 $ au 31/05/2026
Profil
Paul A. Brennan is currently Chief Business Officer at Eupraxia Pharmaceuticals, Inc. since 2022.
Former roles include President, Chief Executive Officer & Director at InMed Pharmaceuticals, Inc.; Chief Executive Officer at MIGENIX, Inc. (2009-2010); Chief Executive Officer at Global Gaming Technologies Corp.
(2010); Chief Executive Officer at Altair Therapeutics, Inc. (2009); President, Chief Executive Officer & Director at NervGen Pharma Corp.
(2019-2022); Director-Business Development & Licensing at Astra Draco AB; Head-Regulatory Affairs at AstraZeneca PLC; President & VP-Business Development at AnorMED, Inc. (2002-2006); Senior Vice President-Business Development at Aspreva Pharmaceuticals Corp.
(2008); Senior Vice President-Business Development at Arbutus Biopharma Corp.
(2010-2015); Chief Business Officer at Eupraxia Pharmaceuticals, Inc. (2019); Vice President-Business Development at Aquinox Pharmaceuticals, Inc. (2016-2018); and Principal at Pacific Biopartners.
Education includes undergraduate and graduate degrees from Queen's University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/01/2026 | 48 500 ( 0,08 % ) | 343 865 $ | 31/05/2026 |
Postes actifs de Paul Brennan
| Sociétés | Poste | Début |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/11/2022 |
Anciens postes connus de Paul Brennan
| Sociétés | Poste | Fin |
|---|---|---|
| NERVGEN PHARMA CORP. | Directeur Général | 22/09/2022 |
| EUPRAXIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/11/2019 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Corporate Officer/Principal | 01/07/2018 |
| ARBUTUS BIOPHARMA CORPORATION | Corporate Officer/Principal | 01/08/2015 |
| GLOBAL GAMING TECHNOLOGIES CORP. | President | 01/09/2010 |
Formation de Paul Brennan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops metal based therapeutics | Health Technology |
InMed Pharmaceuticals, Inc.
 InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Global Gaming Technologies Corp.
 Global Gaming Technologies Corp. Packaged SoftwareTechnology Services Operates as a holding company with interests engages in the e-sports, mobile and console games and digital interactive entertainment businesses | Technology Services |
Eupraxia Pharmaceuticals, Inc.
 Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Astra Draco AB | |
Altair Therapeutics, Inc.
 Altair Therapeutics, Inc. Medical DistributorsDistribution Services Discovers, develops and commercializes antisense drugs | Distribution Services |
Pacific Biopartners | |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
